Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 5/20 | 0.34 |
| ▸ | HTR1B | P28222 | 5/20 | 0.34 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 2/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | ERN1 | O75460 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.31 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13629783 | 0.96 | KCNH2 (0.34) | KCNH2HTR1DHTR1BCDK2GSK3A | |
| SCHEMBL14221591 | 0.85 | SLC6A9 (0.32) | KCNH2HTR1DHTR1BBACE1ALK | |
| SCHEMBL12946118 | 0.82 | LTA4H (0.42) | KCNH2BACE1HDAC2LTA4H | |
| SCHEMBL12943080 | 0.82 | NR4A2 (0.38) | KCNH2HTR1DHTR1BPRKDCBACE1 | |
| SCHEMBL14310760 | 0.81 | PGR (0.39) | KCNH2BACE1ERN1HDAC3HDAC1 | |
| SCHEMBL12310237 | 0.81 | BACE1 (0.35) | KCNH2CDK2GSK3AGSK3BBACE1 | |
| SCHEMBL14221589 | 0.78 | PRMT6 (0.34) | LTA4H | |
| SCHEMBL13615853 | 0.78 | KCNH2 (0.55) | KCNH2HTR1DHTR1BCDK2PRKDC | |
| SCHEMBL13267896 | 0.74 | HDAC2 (0.43) | KCNH2GSK3BBACE1ERN1HDAC3 | |
| SCHEMBL13615898 | 0.73 | KCNH2 (0.50) | KCNH2HTR1DHTR1BERN1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | KCNH2 740/4885HTR1D 1000/4885HTR1B 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.